Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 3 | $12,499,999 |
Sells | 18 | $126,697 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
23 Jan 2023 17:35 | EVLO | Evelo Biosciences Inc | CARRIERE STEPHEN J | Principal Accounting Officer | 23 Jan 2023 | Sale | 151 | 1.0604 | 160 | D |
10 May 2023 21:31 | EVLO | Evelo Biosciences Inc | GILL SIMBA | President & CEO | 08 May 2023 | Sale | 3,537 | 0.1255 | 444 | D |
10 May 2023 21:31 | EVLO | Evelo Biosciences Inc | THORELL MARELLA | Chief Financial Officer | 08 May 2023 | Sale | 38,531 | 0.1255 | 4,836 | D |
10 May 2023 21:31 | EVLO | Evelo Biosciences Inc | BODMER MARK | CSO, President of R&D | 08 May 2023 | Sale | 68,014 | 0.1255 | 8,536 | D |
10 May 2023 21:32 | EVLO | Evelo Biosciences Inc | MCHALE DUNCAN | Chief Medical Officer | 08 May 2023 | Sale | 66,730 | 0.1255 | 8,375 | D |
12 Jun 2023 16:01 | EVLO | Evelo Biosciences Inc | BODMER MARK | CSO, President of R&D | 23 May 2023 | Sale | 22,571 | 0.1418 | 3,201 | D |
13 Jul 2023 17:15 | EVLO | Evelo Biosciences Inc | FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC | 10% | 11 Jul 2023 | Purchase | 3,246,753 | 2.31 | 7,499,999 | I |
13 Jul 2023 17:15 | EVLO | Evelo Biosciences Inc | FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC | 10% | 11 Jul 2023 | Purchase | 1,082,251 | 2.31 | 2,500,000 | I |
13 Jul 2023 17:15 | EVLO | Evelo Biosciences Inc | FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC | 10% | 11 Jul 2023 | Purchase | 1,082,251 | 2.31 | 2,500,000 | I |
09 Aug 2023 20:42 | EVLO | Evelo Biosciences Inc | THORELL MARELLA | Chief Financial Officer | 08 Aug 2023 | Sale | 2,004 | 9.51 | 19,058 | D |
09 Aug 2023 20:42 | EVLO | Evelo Biosciences Inc | MCHALE DUNCAN | Chief Medical Officer | 08 Aug 2023 | Sale | 3,434 | 9.51 | 32,657 | D |
09 Aug 2023 20:43 | EVLO | Evelo Biosciences Inc | GILL SIMBA | President & CEO | 08 Aug 2023 | Sale | 342 | 9.51 | 3,252 | D |
09 Aug 2023 20:44 | EVLO | Evelo Biosciences Inc | BODMER MARK | CSO, President of R&D | 08 Aug 2023 | Sale | 3,128 | 9.51 | 29,747 | D |
29 Sep 2023 16:02 | EVLO | Evelo Biosciences Inc | GILL SIMBA | President & CEO | 28 Sep 2023 | Sale | 1,996 | 3.94 | 7,864 | D |
03 Nov 2023 16:11 | EVLO | Evelo Biosciences Inc | THORELL MARELLA | Chief Financial Officer | 02 Nov 2023 | Sale | 3,999 | 0.33 | 1,320 | D |
03 Nov 2023 16:11 | EVLO | Evelo Biosciences Inc | MCHALE DUNCAN | Chief Medical Officer | 02 Nov 2023 | Sale | 6,854 | 0.33 | 2,262 | D |
03 Nov 2023 16:12 | EVLO | Evelo Biosciences Inc | BODMER MARK | CSO, President of R&D | 02 Nov 2023 | Sale | 6,854 | 0.33 | 2,262 | D |
08 Nov 2023 20:31 | EVLO | Evelo Biosciences Inc | THORELL MARELLA | Chief Financial Officer | 08 Nov 2023 | Sale | 1,811 | 0.33 | 598 | D |
08 Nov 2023 20:31 | EVLO | Evelo Biosciences Inc | GILL SIMBA | President & CEO | 08 Nov 2023 | Sale | 172 | 0.33 | 57 | D |
08 Nov 2023 20:32 | EVLO | Evelo Biosciences Inc | BODMER MARK | CSO, President of R&D | 08 Nov 2023 | Sale | 3,163 | 0.33 | 1,044 | D |
08 Nov 2023 20:32 | EVLO | Evelo Biosciences Inc | MCHALE DUNCAN | Chief Medical Officer | 08 Nov 2023 | Sale | 3,103 | 0.33 | 1,024 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)